A genetically inducible porcine model of intestinal cancer
Open Access
- 7 September 2017
- journal article
- research article
- Published by Wiley in Molecular Oncology
- Vol. 11 (11), 1616-1629
- https://doi.org/10.1002/1878-0261.12136
Abstract
Transgenic porcine cancer models bring novel possibilities for research. Their physical similarities with humans enable the use of surgical procedures and treatment approaches used for patients, which facilitates clinical translation. Here, we aimed to develop an inducible oncopig model of intestinal cancer. Transgenic (TG) minipigs were generated using somatic cell nuclear transfer by handmade cloning. The pigs encode two TG cassettes: (a) an Flp recombinase‐inducible oncogene cassette containing KRAS‐G12D, cMYC, SV40LT – which inhibits p53 – and pRB and (b) a 4‐hydroxytamoxifen (4‐OHT)‐inducible Flp recombinase activator cassette controlled by the intestinal epithelium‐specific villin promoter. Thirteen viable transgenic minipigs were born. The ability of 4‐OHT to activate the oncogene cassette was confirmed in vitro in TG colonic organoids and ex vivo in tissue biopsies obtained by colonoscopy. In order to provide proof of principle that the oncogene cassette could also successfully be activated in vivo, three pigs were perorally treated with 400 mg tamoxifen for 2 × 5 days. After two months, one pig developed a duodenal neuroendocrine carcinoma with a lymph node metastasis. Molecular analysis of the carcinoma and metastasis confirmed activation of the oncogene cassette. No tumor formation was observed in untreated TG pigs or in the remaining two treated pigs. The latter indicates that tamoxifen delivery can probably be improved. In summary, we have generated a novel inducible oncopig model of intestinal cancer, which has the ability to form metastatic disease already two months after induction. The model may be helpful in bridging the gap between basic research and clinical usage. It opens new venues for longitudinal studies of tumor development and evolution, for preclinical assessment of new anticancer regimens, for pharmacology and toxicology assessments, as well as for studies into biological mechanisms of tumor formation and metastasis.Keywords
Funding Information
- Det Frie Forskningsråd (DFF‐4183‐00619, DFF‐0602‐02338B)
- Lundbeckfonden (R180‐2014‐3998, R118‐A11677)
- Kræftens Bekæmpelse (R56‐A2907)
- Styrelsen for Forskning og Innovation (11‐105224)
This publication has 56 references indexed in Scilit:
- Analyses of pig genomes provide insight into porcine demography and evolutionNature, 2012
- A Porcine Model of Familial Adenomatous PolyposisGastroenterology, 2012
- Generation of minipigs with targeted transgene insertion by recombinase-mediated cassette exchange (RMCE) and somatic cell nuclear transfer (SCNT)Transgenic Research, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Structure-guided evolution of cyan fluorescent proteins towards a quantum yield of 93%Nature Communications, 2012
- Pregnancies and piglets from large white sow recipients after two transfer methods of cloned and transgenic embryos of different pig breedsTheriogenology, 2010
- Myelogenous leukemia in adult inbred MHC-defined miniature swine: A model for human myeloid leukemiasVeterinary Immunology and Immunopathology, 2010
- Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant KrasProceedings of the National Academy of Sciences, 2008
- Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressorGenes & Development, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001